If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Rule 38.5 - Pfizer INC

19 Nov 2015 10:52

RNS Number : 2908G
Morgan Stanley Capital Services LLC
19 November 2015
Β 

ο»Ώ

Β 

Β FORM 38.5(a)

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 38.5(a)Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANELΒ ACT,Β 1997, TAKEOVER Β RULES,Β 2013

Β 

DEALINGS BY CONNECTEDΒ EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARYΒ STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

Β 

Β 

1. KEYΒ INFORMATION

Β Name of exempt market-maker

Morgan Stanley Capital Services LLC

Β Company dealt in

PFIZER INC

Β Class of relevant security to which the dealings being disclosed relate (Note 1)

US$0.05 COMMON STOCK

Β Date of dealing

18 NOVEMBER 2015

Β 

Β 

2. DEALINGSΒ (NoteΒ 2)

Β 

(a) PurchasesΒ andΒ sales

Β Total number of relevant secuities accquired

Β Highest price paid (Note 3)

Β Lowest price paid (Note 3)

Β Β 1,936,846

Β 33.4200 USD

Β 32.9500 USD

Β 

Β Total number of relevant secuities disposed

Β Highest price paid (Note 3)

Β Lowest price paid (Note 3)

Β Β 149,039

Β 33.4200 USD

Β 32.9578 USD

Β 

Β 

(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Β Product name, e.g. CFD

Β Nature of transaction

(Note 4)

Β Number of relevant securities

(Note 5)

Β Price per unit

Β CFD

Β LONG

Β 1,200

Β 33.0866 USD

Β CFD

Β LONG

Β 24,736

Β 33.1004 USD

Β CFD

Β LONG

Β 41

Β 33.1335 USD

Β CFD

Β LONG

Β 18

Β 33.1335 USD

Β CFD

Β LONG

Β 9,000

Β 33.2126 USD

Β CFD

Β LONG

Β 165

Β 33.2234 USD

Β CFD

Β LONG

Β 89

Β 33.2236 USD

Β CFD

Β LONG

Β 1,043

Β 33.2245 USD

Β CFD

Β LONG

Β 71

Β 33.2245 USD

Β CFD

Β LONG

Β 22

Β 33.2245 USD

Β CFD

Β LONG

Β 221

Β 33.2245 USD

Β CFD

Β LONG

Β 5

Β 33.2245 USD

Β CFD

Β LONG

Β 19

Β 33.2264 USD

Β CFD

Β LONG

Β 143

Β 33.2520 USD

Β CFD

Β LONG

Β 11

Β 33.2600 USD

Β CFD

Β LONG

Β 2

Β 33.2600 USD

Β CFD

Β LONG

Β 5

Β 33.2600 USD

Β CFD

Β LONG

Β 4

Β 33.2600 USD

Β CFD

Β LONG

Β 300

Β 33.2633 USD

Β CFD

Β LONG

Β 4,046

Β 33.2946 USD

Β CFD

Β LONG

Β 2,683

Β 33.2951 USD

Β CFD

Β LONG

Β 1,400

Β 33.3240 USD

Β CFD

Β LONG

Β 1,600

Β 33.3291 USD

Β CFD

Β LONG

Β 13,800

Β 33.3446 USD

Β CFD

Β LONG

Β 4,174

Β 33.3553 USD

Β CFD

Β SHORT

Β 2,400

Β 33.0300 USD

Β CFD

Β SHORT

Β 10,000

Β 33.0845 USD

Β CFD

Β SHORT

Β 100

Β 33.1100 USD

Β CFD

Β SHORT

Β 100

Β 33.1100 USD

Β CFD

Β SHORT

Β 24

Β 33.1100 USD

Β CFD

Β SHORT

Β 36

Β 33.1100 USD

Β CFD

Β SHORT

Β 6,575

Β 33.1623 USD

Β CFD

Β SHORT

Β 700

Β 33.1771 USD

Β CFD

Β SHORT

Β 34,124

Β 33.1972 USD

Β CFD

Β SHORT

Β 5,000

Β 33.2041 USD

Β CFD

Β SHORT

Β 72,090

Β 33.2131 USD

Β CFD

Β SHORT

Β 29

Β 33.2256 USD

Β CFD

Β SHORT

Β 33

Β 33.2256 USD

Β CFD

Β SHORT

Β 1,814

Β 33.2281 USD

Β CFD

Β SHORT

Β 100

Β 33.2300 USD

Β CFD

Β SHORT

Β 78

Β 33.2400 USD

Β CFD

Β SHORT

Β 6

Β 33.2400 USD

Β CFD

Β SHORT

Β 16

Β 33.2400 USD

Β CFD

Β SHORT

Β 16,660

Β 33.2542 USD

Β CFD

Β SHORT

Β 1,576,340

Β 33.2647 USD

Β CFD

Β SHORT

Β 100

Β 33.2700 USD

Β CFD

Β SHORT

Β 50

Β 33.2700 USD

Β CFD

Β SHORT

Β 22,800

Β 33.2711 USD

Β CFD

Β SHORT

Β 10,200

Β 33.2852 USD

Β CFD

Β SHORT

Β 13,200

Β 33.2879 USD

Β CFD

Β SHORT

Β 31,800

Β 33.2908 USD

Β CFD

Β SHORT

Β 2,100

Β 33.3000 USD

Β CFD

Β SHORT

Β 96,300

Β 33.3174 USD

Β CFD

Β SHORT

Β 714

Β 33.3427 USD

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Β Product name, eg call option

Β Writing, selling, purchasing, varying etc

Β Number of securities to which the option relates (Note 5)

Β Exercise Price

Β Type, e.g American, European etc

Β Expiry Date

Β Option money paid/received per unit (Note 3)

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β 

(ii) Exercising

Β 

Β Product name, eg call option

Β Number of securities

Β Exercise price per unit (Note 3)

Β N/A

Β N/A

Β N/A

Β 

Β 

3. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β Date of disclosure

Β 19 NOVEMBER 2015

Β Contact Name

Craig Horsley

Β Telephone Number

+44(141) 245 7736

Β Name of offeree/offeror with which connected

ALLERGAN PLC

Nature of connection (Note 6)

Advisory

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEBLBMTMBIBBLA
Date   Source Headline
12th May 201411:55 amRNSForm 8.3 - Pfizer, Inc.
12th May 201411:54 amRNSForm 8.5 (EPT/RI) - Pfizer Inc
12th May 201411:39 amRNSForm 8 (DD) - Pfizer Inc.
12th May 201411:38 amRNSRule 2.10 Announcement
12th May 201411:34 amRNSForm 8.5 (EPT/RI) - Pfizer Inc
12th May 201411:33 amRNSForm 8 (DD) - [Pfizer Inc]
12th May 201411:31 amRNSForm 8.5 (EPT/RI) - Pfizer Inc
12th May 201411:31 amRNSForm 8 (DD) - [Pfizer Inc]
12th May 201411:30 amRNSForm 8.5 (EPT/RI)
12th May 201411:26 amRNSForm 8.5 (EPT/RI) - Pfizer Inc
12th May 201411:00 amRNSRule 2.10 Announcement
12th May 201410:53 amRNSForm 8.3 - Pfizer Inc
12th May 201410:52 amRNSForm 8.3 - AstraZeneca Plc
12th May 201410:17 amRNSStatement from Pfizer Inc.
12th May 20147:00 amRNSTHE BENEFITS OF A POTENTIAL COMBINATION
12th May 20147:00 amPRNForm 8.3 - Pfizer Inc.
9th May 20146:23 pmRNSForm 8.3 - Pfizer Inc - Amendment
9th May 20146:20 pmRNSForm 8.3 - Pfizer Inc
9th May 20146:10 pmRNSForm 8.5 (EPT/NON-RI) Amendment
9th May 20146:08 pmRNSForm 8.5 (EPT/NON-RI) Amendment
9th May 20146:06 pmRNSForm 8.5 (EPT/RI) Pfizer INC
9th May 20144:45 pmRNSForm 8 (DD) - [Pfizer Inc] - Amendment
9th May 20144:33 pmRNSForm 8 (DD) - [Pfizer Inc]
9th May 20143:38 pmRNSForm 8.3 - Pfizer Inc
9th May 20143:37 pmBUSForm 8.3 - Pfizer Inc - Amendment
9th May 20143:33 pmRNSForm 8.5 (EPT/RI) - Pfizer Inc
9th May 20143:30 pmRNSForm 8.3 - Pfizer Inc.
9th May 20143:22 pmRNSForm 8.3 - Pfizer Inc.
9th May 20143:11 pmRNSForm 8.3 - Pfizer INC
9th May 20143:10 pmRNSForm 8.3 - Astrazeneca PLC
9th May 20142:33 pmBUSForm 8.3 - Pfizer Inc.
9th May 20142:28 pmBUSForm 8.3 - Pfizer Inc
9th May 20142:28 pmBUSForm 8.3 - Pfizer Inc
9th May 20142:24 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
9th May 20142:22 pmRNSForm 8.3 - [PFIZER INC]
9th May 20142:15 pmRNSForm 8.5 (EPT/RI) Pfizer Inc
9th May 20142:12 pmRNSForm 8.3 - [PFIZER INC]
9th May 20141:58 pmRNSForm 8.5 (EPT/RI) Replacement Pfizer Inc
9th May 20141:57 pmBUSForm 8.3 - Pfizer Inc.
9th May 20141:56 pmRNSForm 8.5 (EPT/RI) - Amendment
9th May 20141:50 pmRNSForm 8 (DD) - Pfizer Inc.
9th May 20141:44 pmRNSForm 8.5 (EPT/NON-RI) Replacement - Pfizer INC
9th May 20141:41 pmRNSForm 8.3 - Pfizer Inc
9th May 20141:09 pmRNSForm 8.3 - AstraZeneca Plc
9th May 20141:08 pmRNSForm 8.3 - Pfizer
9th May 201412:35 pmRNSForm 8.3 - Pfizer Inc
9th May 201412:24 pmRNSForm 8.5 (EPT/NON-RI)
9th May 201412:21 pmRNSForm 8.5 (EPT/RI)
9th May 201412:19 pmRNSForm 8.3 - AstraZeneca Plc
9th May 201412:12 pmRNSForm 8.3 - Pfizer Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.